Neuropathology of mice carrying mutant APPswe and/or PS1M146L transgenes: Alterations in the p75NTR cholinergic basal forebrain septohippocampal pathway

Experimental Neurology

Volumn 170, Issue 2, 2001, Pages 227-243

  Jaffar, Syed ^a   Counts, Scott E ^a   Ma, Shuang Y ^a   Dadko, Elizabeth ^a   Gordon, Marcia N ^b   Morgan, Dave ^b   Mufson, Elliott J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Pharmacology   (United States)

Author keywords

Alzheimer's; Amyloid; Basal forebrain; Cholinergic; Mice; Neuropathology; Neurotrophin; Presenilin; Stereology; Transgenic

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PROTEIN P75;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CHOLINERGIC SYSTEM; CONTROLLED STUDY; FOREBRAIN; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENOTYPE; GLIA CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NERVE CELL; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE;

EID: 0034870817     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7710     Document Type: Article

References (62)

1. Amyloid precursor protein modulates the interaction of nerve growth factor with p75 receptor and potentiates its activation of trkA phosphorylation
2. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules
3. Localization of nerve growth factor-like immunoreactivity in rat nervous tissue
4. Proteolytic fragments of Alzheimer's disease-associated presenilin 1 are present in synaptic organelles and growth cone membranes of rat brain
5. Alzheimer's disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid β-protein deposition is present
6. Evidence that transmitter-containing dystrophic neurites precede those containing paired helical filaments within senile plaques in the entorhinal cortex of nondemented elderly and Alzheimer's disease patients
7. Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits
8. Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: A combined fluorescent tracer and acetylcholinesterase analysis
9. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
10. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease
11. Amygdaloid pathology in Alzheimer's disease: A qualitative and quantitative analysis
12. Age-related decreases in GTP-cyclohydrolase-immunoreactive neurons in the monkey and human substantia nigra
13. The localization of nerve growth factor-like immunoreactivity in the adult rat basal forebrain and hippocampal formation
14. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1
15. Localization of components involved in protein transport and processing through the yeast Golgi apparatus
16. Microglial response to amyloid plaques in APPsw transgenic mice
17. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease
18. Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice
19. Neurogenesis and plasticity of the olfactory sensory neurons
20. Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly
21. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
22. Contrasting role of presenilin-1 and presenilin-2 in neuronal differentiation in vitro
23. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
24. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
25. Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension
26. A central role for astrocytes in the inflammatory response to beta-amyloid: Chemokines, cytokines and reactive oxygen species are produced
27. Nerve growth factor receptor-immunoreactive neurons within the developing human cortex
28. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation
29. An indirect immunofluorescence procedure for staining the same cryosection with two mouse monoclonal primary antibodies
30. Beta-amyloid precursor protein isoforms in various rat brain regions and during brain development
31. Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra
32. The importance of inflammatory mechanisms in Alzheimer disease
33. The nerve growth factor family of receptors
34. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey
35. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth
36. Expression of presenilin 1 in nervous system during rat development
37. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
38. Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice
39. Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease
40. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease
41. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease
42. Entorhinal cortex beta amyloid load in individuals with mild cognitive impairment
43. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain
44. NeuN, a neuronal specific nuclear protein in vertebrates
45. F(ab) secondary antibodies: A general method for double immunolabeling with primary antisera from the same species. Efficiency control by chemiluminescence
46. The cholinergic in old age and Alzheimer's disease
47. Demonstrating immune-related antigens in Alzheimer's disease brain tissue
48. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
49. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease
50. Reduction in trkA immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome
51. Skeletal and CNS defects in presenilin-1-deficient mice
52. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
53. Impaired neurotransmitter systems by Abeta amyloidosis in APPsw transgenic mice overexpressing amyloid beta protein precursor
54. Mitotic mechanisms in Alzheimer's disease?
55. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease
56. Amyloid precursor protein potentiates the neurotrophic activity of NGF
57. Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain
58. Two embryonic, tissue-specific molecules identified by a double-label immunofluorescence technique for monoclonal antibodies
59. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain
60. Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system
61. Rat beta-nerve growth factor sequence and site of synthesis in the adult hippocampus
62. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes